SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Preventive Visit — Wilma Mankiller

PatientWilma Mankiller
Date of birth1991-11-18
IdentifiersMRN HR-ML052-SYN; SSN (made up) 000-52-4183
Document date2026-08-24
AuthorRena Hawkfeather-Lindqvist, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Periodic preventive visit; no new complaints. [S]

History of Present Illness

Ms. Mankiller, a 34-year-old woman with generalized myasthenia gravis, returns for her periodic preventive visit eleven weeks after robotic thymectomy. She completed the health risk assessment beforehand. Her eyelids no longer droop and double vision has not returned; she tires a little by late afternoon. She takes pyridostigmine 60 mg four times daily, prednisone (now 30 mg each morning and tapering), azathioprine 150 mg daily, trimethoprim-sulfamethoxazole three times a week, calcium and vitamin D. She sleeps less well on prednisone and has gained about 3 kg since the spring. She has had no breathlessness, swallowing trouble or infections. She is back at work most days and walks with a cane only on rough ground. She asks which vaccines and screening she needs while on these medicines. [S]

ElementDetail
VisitPeriodic adult preventive visit
Safety eventsNo falls, infections or emergency visits since the thymectomy
MedicinesPyridostigmine 60 mg four times daily; prednisone 30 mg daily, tapering; azathioprine 150 mg daily; trimethoprim-sulfamethoxazole three times weekly; calcium carbonate and cholecalciferol
Active conditionsGeneralized myasthenia gravis after thymectomy; autosomal dominant polycystic kidney disease with normal kidney function; recovery from major trauma
Functional statusIndependent; cane on rough ground

Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]

DomainFinding
Self-rated healthGood and improving
PsychosocialClose ties to her community and work; the year since the crash has been hard; she has people to turn to
TobaccoNever
Alcohol and drugsNone (AUDIT-C 0)
Physical activityWalks most evenings; leg exercises from physical therapy three times a week
NutritionHome-cooked meals; less salt for her kidneys; more hungry on prednisone; drinks about 2.5 liters of water a day
SleepWakes early on prednisone; about six hours
Safety at homeFeels safe at home; no violence or threats (screen negative)
Driving and seat beltsAlways wears a seat belt; drives in daylight
Reproductive healthNot planning pregnancy; reports a reliable method of contraception, not recorded here
Sun exposureWorks outdoors at times; hat and sunscreen advised on azathioprine
PainOccasional aching in the left leg after long days

Review of Systems

SystemResultFinding
ConstitutionalPositiveWeight up about 3 kg on prednisone; mild late-afternoon tiredness; no fever
EyesNegativeNo drooping eyelids or double vision
Ears, nose, mouth, and throatNegativeNo trouble chewing or swallowing; voice normal
CardiovascularNegativeNo chest pain, palpitations or swelling
RespiratoryNegativeNo breathlessness lying flat; cough strong
GastrointestinalNegativeLoose stools on pyridostigmine at times; no abdominal pain
GenitourinaryNegativeNo blood in the urine, flank pain or urinary infections
MusculoskeletalPositiveOccasional left leg ache after long days; no new joint pain
IntegumentaryNegativeHealed thymectomy port sites; no new skin lesions
NeurologicalNegativeNo weakness of the arms or neck; no numbness
PsychiatricNegativeMood steady; sleep shorter on prednisone; PHQ-9 score 3
EndocrineNegativeNo excess thirst or urination

12 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Pyridostigmine bromide 30 mg oral tablet, one tablet three times daily with meals as a trial; take 30 to 45 minutes before eatingOne tablet three times dailyOral route2026-03-09 to 2026-03-23completedS
Pyridostigmine bromide 60 mg oral tablet, one tablet four times daily while awake, 30 to 45 minutes before mealsOne tablet four times daily while awakeOral route2026-03-23 to 2026-10-12completedS
Prednisone 10 mg oral tablet, 10 mg each morning, rising by 10 mg each week to 40 mg each morning, then held at 40 mgOnce each morning; dose as directedOral route2026-03-23 to 2026-07-13completedS
Prednisone 5 mg oral tablet, tapering from 40 mg each morning by 5 mg every two to three weeksOnce each morning; dose as directedOral route2026-07-13activeS
Azathioprine 50 mg oral tablet, one tablet daily for two weeks, then two tablets daily, then three tablets (150 mg, about 2.3 mg/kg) dailyOnce daily; dose as directedOral route2026-05-04activeS
Calcium carbonate 1250 mg (500 mg elemental calcium) oral tablet, one tablet daily with foodOne tablet daily with foodOral route2026-03-23activeS
Cholecalciferol (vitamin D3) 1000 units (0.025 mg) oral tablet, one tablet dailyOne tablet dailyOral route2026-03-23activeS
Sulfamethoxazole 800 mg / trimethoprim 160 mg oral tablet, one tablet three times a week, while prednisone is 20 mg or more with azathioprineOne tablet on Monday, Wednesday and FridayOral route2026-05-04 to 2026-10-05completedS
Acetaminophen 500 mg oral tablet, one or two tablets up to three times daily as needed for leg painOne or two tablets up to three times daily as neededOral route2025-09-15activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-08-24Body height163cmS
2026-08-24Body weight64.2kgS
2026-08-24Body mass index (BMI) [Ratio]24.2kg/m2S
2026-08-24Systolic blood pressure120mm[Hg]S
2026-08-24Diastolic blood pressure76mm[Hg]S
2026-08-24Heart rate72/minS
2026-08-24Respiratory rate14/minS
2026-08-24Body temperature36.6CelS
2026-08-24Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-08-24Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S
2026-08-24Total score [AUDIT-C]0{score}S

Physical Exam

Vital signs recorded on 2026-08-24; see the Vital Signs section. [S]

SystemFinding
ConstitutionalWell; weight 64.2 kg, BMI 24.2; blood pressure 120/76
EyesNo ptosis after one minute of upgaze; eye movements full
NeckNeck flexion strength 5 of 5; no thyroid enlargement
CardiovascularRegular rhythm; no murmur; no edema
RespiratoryClear; healed port sites on the right chest
BreastsClinical breast examination declined; not required at her age
AbdomenSoft; both kidneys palpable, non-tender
MusculoskeletalHealed surgical scars on both legs; walks steadily without the cane in the clinic
NeurologicalArm abduction held for two minutes without fatigue; speech clear while counting to 50
SkinNo suspicious lesions
PsychiatricCalm, direct and engaged

Problems

ProblemClinical statusVerificationCodeProvenance
Drooping eyelids and double vision for six weeks, worse in the evening, with fatigable weakness of the arms and neck, tiring when chewing and a nasal voice after long talks; a disorder of the neuromuscular junction suspectedresolvedconfirmed H53.2S — Synthetic presenting problem, resolved at the second visit when antibodies and nerve testing established myasthenia gravis.
Generalized myasthenia gravis, acetylcholine receptor antibody positive, MGFA class IIa, without thymoma; synthetic modern detail linked to her documented myasthenia gravis of 1980activeconfirmed G70.00S — Synthetic antibody level, electrodiagnosis, class and treatment; the diagnosis less than a year after the crash, and recovery with Cherokee medicine people, surgery and drug therapy, are documented (D).
Autosomal dominant polycystic kidney disease (hereditary, as she has described it), with normal kidney function; to be stagedactiveconfirmed Q61.2S — The hereditary polycystic kidney disease is documented (D) from her later public account; its detection before the index date, and every value, are synthetic.
Recovery from major trauma in a head-on car crash last year: fractures of both legs, ribs and face, with many operations; walks independently, with a cane on rough groundactiveconfirmed Z87.81S — The crash, the operations and the injuries are documented (D); the current function is synthetic.
Long-term glucocorticoid therapy for myasthenia gravis, with monitoring of glucose, blood pressure, weight, bone health, mood, sleep, eyes and infectionactiveconfirmed Z79.52S — Synthetic treatment plan.
Azathioprine as steroid-sparing therapy, with blood count and liver test monitoringactiveconfirmed Z79.624S — Synthetic treatment plan.
Acquired absence of the thymus after robotic extended thymectomy for myasthenia gravis (pathology: thymic follicular hyperplasia, no thymoma)activeconfirmed Z90.89S — Synthetic: recorded after the thymectomy; the sources name surgery among her treatments without saying which.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Blood pressure screeningCompleted today120/76 mm Hg
Depression screeningCompleted todayPHQ-9 score 3
Unhealthy alcohol use screeningCompleted todayAUDIT-C score 0
Tobacco useCompleted todayNever
Intimate partner violence screeningCompleted todayNegative; she feels safe at home
Cervical cancer screeningUp to dateHPV test two years ago, negative; on long-term immunosuppression the interval will be reviewed with her at the next visit
Breast cancer screeningNot indicatedMammography every two years begins at 40
HIV screeningOrderedOnce for adults 15 to 65; no record of a test; drawn today
Hepatitis C screeningOrderedOnce for adults 18 to 79; drawn today with the HIV test
Hepatitis BUp to dateScreened before azathioprine at the second visit: surface antigen and core antibody negative, surface antibody positive from childhood vaccination
Pneumococcal vaccineUp to datePCV20 at the second visit, before immunosuppression; no further doses needed
Recombinant zoster vaccineCompleted todayDose 2 given today; series complete
Influenza vaccineDueInactivated vaccine when this season's supply arrives; no live vaccines on azathioprine
COVID-19 vaccineDueThis season's vaccine in the autumn; she is on immunosuppression
Tetanus, diphtheria and pertussisUp to dateTdap given in hospital after the crash last year
Measles, mumps, rubella and varicella vaccinesNot indicatedLive vaccines are not given on azathioprine and prednisone; immunity to be checked if exposure occurs
HPV vaccineNot indicatedOver 26; shared decision offered for 27 to 45 and not wanted
Folic acidNot indicatedNot planning pregnancy; 0.4 to 0.8 mg daily advised before any planned pregnancy, which should also be planned with neuromuscular neurology because of her medicines
Cholesterol screeningNot indicatedStatin screening begins at 40; no diabetes or other indication
Bone health on glucocorticoidsUp to dateDXA at the third visit: Z-scores normal; calcium and vitamin D daily
Skin cancer preventionCompleted todayCounseled on hat and sunscreen; yearly skin check on azathioprine

Immunizations given today: Recombinant zoster vaccine, dose 2 of 2 [S]

Guideline basis: Sanders DB, et al. International consensus guidance for management of myasthenia gravis: Executive summary. Neurology 2016;87(4):419-425 (2016); Adult Immunization Schedule by Medical Condition and Other Indication (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026)

Follow-up: Seven-month review in seven weeks with neuromuscular neurology input, blood count, liver and kidney tests, hemoglobin A1c and urine albumin. Influenza and COVID-19 vaccines then. Next preventive visit in one year. Next scheduled visit 2026-10-12: seven-month review: minimal manifestation status, prednisone and pyridostigmine reduction, azathioprine safety, kidney screening, and plans for the year. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 20 minutes, with her consent. She named a health care agent, and a health care proxy form was completed; the agent is recorded in the chart and is not named here. She said that what matters most to her is to keep working for her community, to be told plainly what is happening, and to make her own decisions, with her own Cherokee medicine respected. She chose not to record specific treatment preferences today, and knows that the plan can be updated at any visit. [S]